Isolation of a small molecule inhibitor of DNA base excision repair

Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Ian D. Hickson(University of Copenhagen), Paul J. Shrimpton(University of Birmingham), Michael J.E. Sternberg(Imperial College London), Denis Talbot(Cancer Research UK), Tim Hammonds, L. Gardiner(Cancer Research UK), Jason L. Parsons(University of Birmingham), P. A. Freemont(Institute of Structural and Molecular Biology), Grigory L. Dianov(Novosibirsk State University), S Houlbrook(Cancer Research UK), Frank W. Smart
Nucleic Acids Research
August 19, 2005
10.1093/nar/gki781
Cited by 240

Related Papers

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
Knowledge-based prediction of protein structures and the design of novel molecules
|Nature|1987|655
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|The Lancet Oncology|2013|605
Identification and application of the concepts important for accurate and reliable protein secondary structure prediction
|Protein Science|1996|462